Should methyldibromo glutaronitrile continue to be used in the European baseline Series? A REIDAC national cross-sectional study.
Mercader-García P, Pastor-Nieto MA, Gonzalez-Perez R, Cordoba-Guijarro S, Gimenez-Arnau AM, Ruiz-Gonzalez I, Mora-Fernández V, Miquel J, Silvestre-Salvador JF, Ortiz-Frutos FJ, Sanz-Sanchez T, Rodriguez-Serna M, Perez-Feal P, Sánchez-Pérez J, Heras-Mendaza F, Serra-Baldrich E, Zaragoza-Ninet V, Hervella-Garces M, Gatica-Ortega ME, García-Doval I, Descalzo MÁ, Borrego L; REIDAC group.
Mercader-García P, et al. Among authors: miquel j.
Contact Dermatitis. 2021 Nov;85(5):572-577. doi: 10.1111/cod.13837. Epub 2021 Apr 15.
Contact Dermatitis. 2021.
PMID: 33745152